European Reference Laboratory Network for Human Influenza (ERLI-Net)
The ERLI-Net sub-network of reference laboratories of the European Influenza Surveillance Network carries out virological surveillance of human influenza in the EU/EEA through the EISN timely reporting mechanism and strengthening laboratory capacity for influenza virus detection, antiviral susceptibility testing and typing.
About the network
The main objectives of ERLI-Net are to carry out virological surveillance of human influenza and to ensure that data are shared through the European Influenza Surveillance Network (EISN) reporting mechanisms in a timely manner.
Influenza laboratory quality control
In accordance with the Key Tasks, ERLI-Net laboratories should participate in external quality assurance (EQA) schemes. EQA panels are distributed by both ERLI-Net and the WHO.
Summary report: Joint ECDC/WHO Europe Meeting on Influenza Surveillance
This report, originally published by WHO/Europe, summarizes ECDC and WHO/Europe's first joint influenza surveillance meeting, held on 7-9 June 2011 and hosted by the Slovenian Ministry of Health.
Influenza virus characterisation, Summary Europe, June 2017
In the course of the 2016–2017 influenza season, nearly 146 000 influenza detections across the EU/EAA region have been reported.
Influenza virus characterisation, Summary Europe, July 2017
In the course of the 2016–17 influenza season, nearly 146 000 influenza detections have been reported across the WHO European Region.
Influenza surveillance for the 2017-2018 season is starting
ECDC monitors and reports on influenza transmission and virus circulation in Europe on a weekly basis throughout the flu season, in collaboration with WHO Regional Office for Europe, in the report Flu News Europe.
Influenza virus characterisation, Summary Europe, September 2017
In the course of the 2016–17 influenza season, over 146 000 influenza detections across the WHO Europe Region have been reported.
WHO Europe: Influenza
WHO/Europe aim to reduce influenza-related morbidity and mortality by strengthening virological and epidemiological surveillance for mild and severe influenza; using surveillance data to estimate the burden of influenza in order to prioritize national influenza vaccination programmes; and maintaining and strengthening pandemic preparedness activities at the national level. WHO/Europe also monitors the emergence of other respiratory pathogens that have the potential to spread among humans. These include coronaviruses, which cause a range of illnesses from severe acute respiratory syndrome (SARS) and Middle East respiratory syndrome coronavirus (MERS-CoV) to the common cold.
WHO: Global influenza updates
The summaries of global surveillance are based on data gathered through global and regional data sharing platforms, and direct reports from Member States.